Blood Flow Restriction Training in Knee Osteoarthritic Patients

November 2, 2026 updated by: Riphah International University

Comparison of Band Tissue Flossing Method and Traditional Cuff Method for Blood Flow Restriction Training in Patients With Knee Osteoarthritis

The aim of this study was to compare the effect of band tissue flossing method and traditional cuff method for blood flow restriction training on pain, range of motion, muscle strength and functional status in patients with knee osteoarthritis. Symptoms of this condition limit patient's ability to perform high load strengthening. Blood flow restraining training allows strengthening with lower loads. 46 subjects will be divided in two groups, 23 subjects in each group. knee extension and knee press exercises will be performed. In group A floss band was tied on thigh and in group B pneumatic cuff was applied on thigh. 40-60 years individual with knee osteoarthritis will be included. outcome measures will be assessed at baseline, after 1st session, after 2nd week and after 4th week.

Study Overview

Study Type

Interventional

Enrollment (Actual)

46

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Federal
      • Islamabad, Federal, Pakistan, 44000
        • Pakistan Institute of Medical Sciences (P.I.M.S.)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age 40-60 years
  • Pain more than or equal to 3 on NPRS
  • Range of motion ≤ 100-degree flexion and ≤ 0-degree extension
  • Those who have knee osteoarthritis, according to KL (Grade 1 and 2)
  • Genders: Male and Female

Exclusion Criteria:

  • Cardiovascular condition e.g., hypertension, thromboembolism, lymphatic diseases etc.
  • Muscle/tendon/ ligament injuries
  • Any surgery, skin infection, trauma, pregnancy, fracture and fall
  • Patient with intra articular steroidal therapy with in last 6 months
  • Patient unwilling to participate and comply with the study session

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Blood flow restriction with Floss band (group A)

seated knee extension and knee press while floss band is tied at proximal thigh.

seated knee extension exercise and knee press exercises (4 sets; repetitions: 30,15,15,15) performed for four weeks with three sessions per week. Exercises performed with 20% of one repetition maximum. Floss band was tied at proximal thigh with 50% stretch in proximal to distal direction starting from above the patella and moving towards groin.

Experimental: Blood flow restriction with pneumatic cuff (group B)

seated knee extension and knee press exercises with pneumatic cuff tied at proximal thigh

seated knee extension exercises and knee press exercises (4 sets; repetitions: 30,15,15,15) performed for four weeks with three sessions per week. Exercises performed with 20% of one repetition maximum. Clinical cuff was tied at proximal thigh with 40% of limb occlusion pressure.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Numeric Pain Rating Scale (NPRS)
Time Frame: 4th week

Changes from baseline will be assessed using NPRS scale. It is a one-dimensional measure of pain severity in adults including those suffering from chronic pain. Scale has ratings of 0 to 10, with higher points indicating higher levels of pain severity. it is a valid tool for assessing pain in knee OA patients.

4th week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knee Flexion Range of motion
Time Frame: 4th week

Changes in knee flexion range of motion from baseline will be assessed using universal goniometer. Goniometer is the most common instrument utilized for measuring available range of motion. Universal Goniometer Comes in two variations one is short arm whereas one is long arm. The one with short arm is used for smaller joints like the wrist, elbow, or ankle. On the other hand, long arm goniometers provide greater accuracy for knee and hip joints which have long bones acting as levers

4th week
Knee Extension Range of Motion
Time Frame: 4th week

Changes from baseline in knee extension range of motion will be assessed with goniometer. It is the most common instrument utilized for measuring available range of motion. Universal Goniometer Comes in two variations one is short arm whereas one is long arm. The one with short arm is used for smaller joints like the wrist, elbow, or ankle. On the other hand, long arm goniometers provide greater accuracy for knee and hip joints which have long bones acting as levers

4th week
Quadriceps strength (dynamometer)
Time Frame: 4th week

Quadriceps muscle strength changes from baseline will be assessed using crane scale dynamometer. Participant sits in chair with hips and knees flexed to 90 degrees. The hook of dynamometer is secured to the ankle with a strap, while from behind the dynamometer is fixed to leg of chair to provide a stable anchor. As the participant performs knee extension the force generated is recorded in newtons or kilograms. It is a valid and reliable tool for assessing strength of knee extensors.

4th week
Western Ontario and McMaster Universities (WOMAC) index
Time Frame: 4th week

WOMAC index was developed in order to fill the need for an outcome instrument that could be responsive to change in OA-related symptoms following a clinical trial. It includes five questions about pain, two about stiffness, and seventeen on degree of disability of activities of daily living. total score is converted to percentage. higher scores mean severe symptoms.

4th week
30 Second Sit to Stand Test (STS)
Time Frame: 4th week

The 30 Second Sit to Stand Test (STS) is also known as 30 Second Chair Stand Test (30CST), was initially designed for testing leg strength and endurance in older adults. It is used for adults of 18-64 years, older adults (65 years and above), and people with osteoarthritis. A person stands up and sits down five times as quickly and safely as possible, with their arms folded across their chest, A longer time indicates weaker leg strength and a greater risk of falls. It records the number of times a person can sit and stand within 30 seconds

4th week
Timed Up and Go Test (TUG)
Time Frame: 4th week

This test is for assessing ambulatory transition in knee OA patients. For this test participant stands from armed chair, walks with comfortable pace to a line 3 m away, at end point turns, and returns to sitting position in chair. Participant can't use walking aid during task. Time is recorded in which task is done.

4th week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Muhammad Affan Iqbal, PhD*, Riphah International University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 30, 2026

Primary Completion (Actual)

October 30, 2026

Study Completion (Actual)

October 30, 2026

Study Registration Dates

First Submitted

February 4, 2026

First Submitted That Met QC Criteria

February 4, 2026

First Posted (Actual)

February 11, 2026

Study Record Updates

Last Update Posted (Actual)

November 3, 2026

Last Update Submitted That Met QC Criteria

November 2, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe